New insight into coronary endothelial dysfunction: role of endothelin

C R Cannan1, V Mathew, A Lerman

  • 1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

Insights

Endothelin, a vasoconstrictor from the coronary endothelium, contributes to endothelial dysfunction in cardiovascular diseases. This review explores its role and potential therapies for improving coronary vascular tone.

Area of Science:

  • Cardiovascular Medicine
  • Endothelial Biology
  • Pharmacology

Background:

  • The coronary endothelium regulates vascular tone through vasoactive mediators.
  • Coronary endothelial dysfunction is linked to cardiovascular diseases, causing an imbalance in these mediators.
  • Endothelin, a potent vasoconstrictor, is produced by the endothelium and implicated in endothelial dysfunction.

Purpose of the Study:

  • To review the relationship between endothelin and coronary endothelial dysfunction.
  • To examine this relationship in various cardiovascular disease states.
  • To explore potential therapeutic strategies targeting endothelin.

Main Methods:

  • Literature review of studies on endothelin and coronary endothelial function.
  • Analysis of the role of endothelin in different cardiovascular conditions.
  • Synthesis of information on current and potential therapeutic interventions.

Main Results:

  • Endothelin contributes significantly to the pathogenesis of coronary endothelial dysfunction.
  • Elevated endothelin levels are observed in several cardiovascular diseases associated with endothelial dysfunction.
  • Therapeutic strategies aimed at blocking endothelin's effects show promise.

Conclusions:

  • Endothelin plays a critical role in coronary endothelial dysfunction across various cardiovascular diseases.
  • Targeting endothelin pathways represents a viable therapeutic approach for managing these conditions.
  • Further research is warranted to fully elucidate endothelin's therapeutic potential.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...